BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Prognosis
24 results:

  • 1. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
    Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
    Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in colorectal cancer.
    Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The prognostic role of metastatic lymph node ratio in colon cancer: a retrospective cohort study on 241 patients in a single center.
    Cozzani F; Agnesi S; Dell'abate P; Rossini M; Viani L; Pedrazzi G; Del Rio P
    Minerva Surg; 2023 Apr; 78(2):155-160. PubMed ID: 36193952
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of a prognostic signature in colorectal cancer using combinatorial algorithm-driven analysis.
    Alnabulsi A; Wang T; Pang W; Ionescu M; Craig SG; Humphries MP; McCombe K; Salto Tellez M; Alnabulsi A; Murray GI
    J Pathol Clin Res; 2022 May; 8(3):245-256. PubMed ID: 35043584
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chylous ascites has a higher incidence after robotic surgery and is associated with poor recurrence-free survival after rectal cancer surgery.
    Wang X; Zheng Z; Chen M; Huang S; Lu X; Huang Y; Chi P
    Chin Med J (Engl); 2021 Dec; 135(2):164-171. PubMed ID: 34954713
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]    [Full Text] [Related]  

  • 8. Marital status and survival of patients with colorectal signet ring cell carcinoma: a population-based study.
    Feng L; Yang YJ; Du J; Yu YJ; Diao JD
    Sci Rep; 2020 Oct; 10(1):17881. PubMed ID: 33087758
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating ccne1.
    Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX
    J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Population-based Screening for
    Chu JE; Johnson B; Kugathasan L; Morris VK; Raghav K; Swanson L; Lim HJ; Renouf DJ; Gill S; Wolber R; Karsan A; Kopetz S; Schaeffer DF; Loree JM
    Clin Cancer Res; 2020 Sep; 26(17):4599-4605. PubMed ID: 32571791
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma.
    Li SH; Lu HI; Chen YH; Lo CM; Huang WT; Tien WY; Lan YC; Tsai HT; Chen CH
    Surgery; 2019 May; 165(5):946-952. PubMed ID: 30678869
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
    Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
    Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of colorectal cancer.
    Liu X; Pan B; Sun L; Chen X; Zeng K; Hu X; Xu T; Xu M; Wang S
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):746-754. PubMed ID: 29739748
    [No Abstract]    [Full Text] [Related]  

  • 15. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
    Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
    J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The clinicopathological features and prognosis of tumor MSI in East Asian colorectal cancer patients using NCI panel.
    Zheng J; Huang B; Nie X; Zhu Y; Han N; Li Y
    Future Oncol; 2018 Jun; 14(14):1355-1364. PubMed ID: 29366338
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
    He W; Wei M; Yang X; Chen B; Wu Q; Zheng E; Deng X; Wang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6607. PubMed ID: 28445257
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.
    Hinsch A; Buchholz M; Odinga S; Borkowski C; Koop C; Izbicki JR; Wurlitzer M; Krech T; Wilczak W; Steurer S; Jacobsen F; Burandt EC; Stahl P; Simon R; Sauter G; Schlüter H
    J Mass Spectrom; 2017 Mar; 52(3):165-173. PubMed ID: 28117928
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
    Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Heterogeneity of Tumor Sizes in Multiple Pulmonary Metastases of colorectal cancer as a Prognostic Factor.
    Maniwa T; Mori K; Ohde Y; Okumura T; Boku N; Hishida T; Sakao Y; Yoshiya K; Hyodo I; Kondo H
    Ann Thorac Surg; 2017 Jan; 103(1):254-260. PubMed ID: 27743634
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.